Format

Send to

Choose Destination
See comment in PubMed Commons below
Pediatr Dermatol. 2013 Nov-Dec;30(6):751-2. doi: 10.1111/pde.12229. Epub 2013 Oct 11.

Dramatic shift in the infantile hemangioma treatment paradigm at a single institution.

Author information

1
Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin.

Abstract

Historically the first line of treatment for infantile hemangiomas (IHs) has been oral corticosteroids, but because of recent discoveries recognizing the effectiveness of oral and topical beta-blockers, IH management is dynamically changing. With these new treatment options, some physicians are altering the way they manage IHs despite having little evidence-based data on the treatment methods. Highlighting treatment changes at a single large tertiary pediatric referral center, we conclude that despite the numerous studies already published on this topic, more reliable prospective studies are needed to determine the safety, efficacy, and best treatment algorithms for the use of topical and oral beta-blockers for the treatment of IHs.

PMID:
24117504
PMCID:
PMC3984459
DOI:
10.1111/pde.12229
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley Icon for PubMed Central
    Loading ...
    Support Center